RAMIPRIL RELATED COMPOUND A (20 MG) ((2S,3AS,6AS)-1 -[(S)2-[[(S)1 -(METHOXYCARBONYL)-3-PHENYLPROPYL]AMINO]-1-OXOPROPYL]-OCTAHYDRO-CYCLOPENTA[B]PYRROLE-2-CARBOXYLIC ACID)
|
|
- CAS-Nr.
- 91224-69-0
- Englisch Name:
- RAMIPRIL RELATED COMPOUND A (20 MG) ((2S,3AS,6AS)-1 -[(S)2-[[(S)1 -(METHOXYCARBONYL)-3-PHENYLPROPYL]AMINO]-1-OXOPROPYL]-OCTAHYDRO-CYCLOPENTA[B]PYRROLE-2-CARBOXYLIC ACID)
- Synonyma:
- RaMipril Related CoMpound A;Ranitidine Related CoMpound A;Ranitidine diamine hemifumarate;Ranitidine Related Compound Impurity-A;Ranitidine USP Related Compound A Fumarate salt;Ranitidine Related Compound A(Secondary Standards traceble to USP);2-(((5-((Dimethylamino)methyl)furan-2-yl)methyl)thio)ethanamine Fumarate;5-[[(2-aMinoethyl)thio]Methyl]-N,N-diMethyl-2-furanMethanaMine heMifuMarate;Ranitidine Related Compound A (5-[[(2-aminoethyl)thio]methyl]-N,N-dimethyl-2-furanmethanamine, hemi (1598507);Ramipril Related Compound A ((2S,3aS,6aS)-1-[(S)2-[[(S)-1-(methoxycarbonyl)-3-phenylpropyl]amino]-1 (1598314)
- CBNumber:
- CB3501427
- Summenformel:
- C14H22N2O5S
- Molgewicht:
- 330.4
- MOL-Datei:
- 91224-69-0.mol
|
RAMIPRIL RELATED COMPOUND A (20 MG) ((2S,3AS,6AS)-1 -[(S)2-[[(S)1 -(METHOXYCARBONYL)-3-PHENYLPROPYL]AMINO]-1-OXOPROPYL]-OCTAHYDRO-CYCLOPENTA[B]PYRROLE-2-CARBOXYLIC ACID) Eigenschaften
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
WGK Germany |
3 |
|
|
HS Code |
2933997500 |
|
|
Bildanzeige (GHS) |
|
Alarmwort |
Achtung |
Gefahrenhinweise |
Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
H317 |
Kann allergische Hautreaktionen verursachen. |
Sensibilisierung der Haut |
Kategorie 1A |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P261, P272, P280, P302+P352,P333+P313, P321, P363, P501 |
H334 |
Kann bei Einatmen Allergie, asthmaartige Symptome oder Atembeschwerden verursachen. |
Sensibilisierung der Atemwege |
Kategorie 1 |
Achtung |
src="/GHS08.jpg" width="20" height="20" /> |
P261, P285, P304+P341, P342+P311,P501 |
H335 |
Kann die Atemwege reizen. |
Spezifische Zielorgan-Toxizit?t (einmalige Exposition) |
Kategorie 3 (Atemwegsreizung) |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
|
|
Sicherheit |
P261 |
Einatmen von Staub vermeiden. |
P280 |
Schutzhandschuhe/Schutzkleidung/Augenschutz tragen. |
P342+P311 |
Bei Symptomen der Atemwege: GIFTINFORMATIONSZENTRUM/Arzt/... (geeignete Stelle für medizinische Notfallversorgung vom Hersteller/Lieferanten anzugeben) anrufen. |
|
RAMIPRIL RELATED COMPOUND A (20 MG) ((2S,3AS,6AS)-1 -[(S)2-[[(S)1 -(METHOXYCARBONYL)-3-PHENYLPROPYL]AMINO]-1-OXOPROPYL]-OCTAHYDRO-CYCLOPENTA[B]PYRROLE-2-CARBOXYLIC ACID) Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
2-(((5-((Dimethylamino)methyl)furan-2-yl)methyl)thio)ethanamine Fumarate is a ranitidine related compound. Ranitidine is a histamine H2-receptor antagonist which inhibits gastric acid secretion. An Antiulcerative.
Allgemeine Beschreibung
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Ranitidine Related Compound A is an impurity of ranitidine, an inhibitor of gastric acid secretion. Ranitidine is widely used for treating gastric and duodenal ulcers.
RAMIPRIL RELATED COMPOUND A (20 MG) ((2S,3AS,6AS)-1 -[(S)2-[[(S)1 -(METHOXYCARBONYL)-3-PHENYLPROPYL]AMINO]-1-OXOPROPYL]-OCTAHYDRO-CYCLOPENTA[B]PYRROLE-2-CARBOXYLIC ACID) Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
RAMIPRIL RELATED COMPOUND A (20 MG) ((2S,3AS,6AS)-1 -[(S)2-[[(S)1 -(METHOXYCARBONYL)-3-PHENYLPROPYL]AMINO]-1-OXOPROPYL]-OCTAHYDRO-CYCLOPENTA[B]PYRROLE-2-CARBOXYLIC ACID) Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 17)Lieferanten
91224-69-0()Verwandte Suche:
- RAMIPRIL RELATED COMPOUND A (20 MG) ((2S,3AS,6AS)-1 -[(S)2-[[(S)1 -(METHOXYCARBONYL)-3-PHENYLPROPYL]AMINO]-1-OXOPROPYL]-OCTAHYDRO-CYCLOPENTA[B]PYRROLE-2-CARBOXYLIC ACID)
- Ranitidine Related Compound A (50 mg) (5-[[(2- aminoethyl)thio]methyl]-N,N-dimethyl-2-furan- methanamine hemifumarate)
- 5-[[(2-aMinoethyl)thio]Methyl]-N,N-diMethyl-2-furanMethanaMine heMifuMarate
- Ranitidine Related CoMpound A
- RaMipril Related CoMpound A
- Ranitidine Related Compound A (50 mg) (5-[[(2-aminoethyl)thio]methyl]-N,N-dimethyl-2-furanmethanamine, hemifumarate salt)
- RAMIPRIL RELATED COMPOUND A (20 MG) ((2S,3AS,6AS)-1 -[(S)2-[[(S)1 -(METHOXYCARBONYL)-3-PHENYLPROPYL]AMINO]-1-OXOPROPYL]-OCTAHYDRO-CYCLOPENTA[B]PYRROLE-2-CARBOXYLIC ACID)
- Ranitidine diamine hemifumarate
- Ranitidine EP Impurity B Fumarate/Ranitidine USP Related Compound A Fumarate/Ranitidine Aminoethyl Fumarate/2-(((5-((Dimethylamino)methyl)furan-2-yl)methyl)thio)ethanamine Fumarate
- 2-(((5-((Dimethylamino)methyl)furan-2-yl)methyl)thio)ethanamine Fumarate
- Ranitidine Related Compound A(Secondary Standards traceble to USP)
- Ranitidine Related Compound A (5-[[(2-aminoethyl)thio]methyl]-N,N-dimethyl-2-furanmethanamine, hemi (1598507)
- Ramipril Related Compound A ((2S,3aS,6aS)-1-[(S)2-[[(S)-1-(methoxycarbonyl)-3-phenylpropyl]amino]-1 (1598314)
- Ranitidine USP Related Compound A Fumarate salt
- Ranitidine Related Compound Impurity-A
- 91224-69-0